Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
Maria Elisa Mancuso,1 Pier Mannuccio Mannucci21Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 2Scientific Direction, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, ItalyAbstract: Prophylaxis with regular infusions of factor VIII (FVIII)- or factor IX (FIX)- containin...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2014-03-01
|
| Edice: | Drug Design, Development and Therapy |
| On-line přístup: | http://www.dovepress.com/fc-fusion-technology-and-recombinant-fviii-and-fix-in-the-management-o-peer-reviewed-article-DDDT |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|